Affiliations 

  • 1 Centre for Advanced Studies in Botany, University of Madras (Guindy Campus), Chennai, India-600 025
  • 2 Department of Pharmacology, Saveetha Dental College, Saveetha University, Chennai, India
  • 3 Centre for Biotechnology, Anna University, Chennai - 600 025
  • 4 Biomedical Research Unit and Laboratory Animal Centre-Dental Research Cell, Saveetha Dental College, Saveetha University, Chennai, India
  • 5 Department of Biotechnology, Periyar University (PG Extension Centre), Dharmapuri - 636701
  • 6 Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW, 2007, Australia
  • 7 Department of Life sciences, School of Pharmacy, International Medical University, Bukit Jalil ,57000,Kualalumpur, Malaysia
  • 8 Department of Chemical Technology, Chulalongkorn University, Bangkok,Thailand
Bioinformation, 2020;16(11):965-973.
PMID: 34803274 DOI: 10.6026/97320630016965

Abstract

Astaxanthin (AXN) is known to have health benefits by epidemiological studies. Therefore, it is of interest to assess the effect of AXN (derived from indigenous unicellular green alga Haematococcus lacustris) to modulate cell cycle arrest, lysosomal acidification and eventually apoptosis using in vitro in A549 lung cancer cells. Natural extracts of astaxanthin were obtained by standardized methods as reported earlier and characterized by standard HPLC and MS. Treatment of A549 cells with AXN (purified fraction) showed significant reduction in cell viability (about 50%) as compared to crude extract at 50µM concentration. Thus, we show the anticancer effects and lysosomal acidification in A549 cells by Astaxanthin from Haematococcus lacustris for further consideration. Together, our results demonstrated the anticancer potential of AXN from Haematococcus lacustris, which is found to be mediated via its ability to induce cell cycle arrest, lysosomal acidification and apoptotic induction.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.